More about the project

Preclinical Trials

In addition to molecules and standardized extracts already backed by clinical studies, research compounds —those supported only by scientific literature— must undergo a preclinical evaluation phase.

At this stage, their toxicity is assessed and key biomarkers and pharmacological indicators are identified. This process helps determine the pharmacological viability of each compound. RHIZOPHARM conducts these trials in accredited laboratories under strict quality standards.

Our Commitment

This project not only aims to transform the production of active ingredients, but also to become a benchmark in sustainability, scientific innovation, and international collaboration.

Thanks to the alliance between academia, industry, and applied research centers, we are building a pharmaceutical development model that is more ethical, efficient, and environmentally conscious.